|
1,966
|
| 15363 |
HSC (CD150+CD48-CD41-Lin-)
|
|
interacts (colocalizes) with
|
sinusoidal endothelium (MECA-32+)
|
in mobilized spleen (62% of the cells)
|
in vivo
|
| 28832 |
HSC (CD150+CD48-CD41-Lin-)
|
|
interacts (colocalizes) with
|
sinusoidal endothelium (MECA-32+)
|
in bone marrow ( about 57% of the cells)
|
in vivo
|
| 28836 |
HSC (CD150+CD48-CD41-Lin-)
|
|
interacts (colocalizes) with
|
endosteum
|
in bone marrow ( about 14% of the cells)
|
in vivo
|
|
15989959
|
|
2,140
|
| 35937 |
dormant-HSC (LRC, Kit+)
|
|
interacts (colocalizes) with
|
endosteum
|
|
in vivo
|
|
19062086
|
|
2,569
|
| 24180 |
HSC (Tie2+Mpl+)
|
|
interacts (colocalizes) with
|
endosteum (Thpo+)
|
and are highly quiescent cells
|
in vivo
|
| 25887 |
HSC (CD34-Mpl+KSL)
|
|
interacts (colocalizes) with
|
osteoblast (ALP+Thpo+)
|
|
in vivo
|
|
18371409
|
|
2,628
|
| 24965 |
HSC (Tie2+SP,KSL)
|
|
interacts (colocalizes) with
|
endosteum
|
|
in vivo
|
| 25042 |
HSC (Tie2+SP,KSL)
|
|
interacts (colocalizes) with
|
osteoblast (osteocalcin+)
|
|
in vivo
|
|
15260986
|
|
2,756
|
| 25506 |
HSC (LRC)
|
|
interacts (colocalizes) with
|
SNO cell (N-cadherin+CD45-)
|
LT-HSCs are only attached to SNO cells that line the bone surface.
|
in vivo
|
| 26919 |
SNO cell (N-cadherin+CD45-)
|
|
interacts (colocalizes) with
|
trabecular bone
|
|
|
| 35823 |
HSC (N-cadherin+CD45+KSL)
|
|
interacts (colocalizes) with
|
SNO cell (N-cadherin+CD45-)
|
LT-HSCs are only attached to SNO cells that line the bone surface.
|
in vivo
|
|
14574412
|
|
2,766
|
| 25666 |
HSC (CD150+CD48-CD41-)
|
|
interacts (colocalizes) with
|
CAR cell
|
|
in vivo
|
| 26811 |
HSC (Sca1+Kit+)
|
|
interacts (colocalizes) with
|
CAR cell
|
|
in vivo
|
|
17174120
|
|
2,827
|
| 26381 |
HSC (endCD150+CD48-KSL)
|
|
interacts (colocalizes) with
|
endosteum
|
5 to 15 hours after transplantation
|
in vivo
|
| 34738 |
HSC (centCD150+CD48-KSL)
|
|
interacts (colocalizes) with
|
central BM
|
5 to 15 hours after transplantation
|
in vivo
|
|
20631378
|
|
2,830
|
| 26124 |
HSC (CD135-KSL)
|
|
interacts (colocalizes) with
|
osteoblast (osterix+)
|
5-8 h after transplantation into irradiated mice
|
|
| 26129 |
HSC (CD135-KSL)
|
|
interacts (colocalizes) with
|
trabecular bone (Col2.3-GFP+)
|
after transplantation into irradiated mice
|
in vivo
|
| 26136 |
HSC (CD135-KSL)
|
|
interacts (colocalizes) with
|
osteoblast (N-cadherin+)
|
|
in vivo
|
|
19052548
|
|
2,862
|
| 26906 |
osteoblast (Ebf2+)
|
|
interacts (colocalizes) with
|
HSC (Sca1+)
|
|
in vivo
|
|
20887955
|
|
2,923
|
| 26773 |
HSC (CD34-KSL)
|
|
interacts (colocalizes) with
|
vascular endothelial cell (PECAM1+)
|
5 hours after transplantation. This association is dependent on ROS, which induces the expression of VCAM1
|
in vivo
|
|
19797522
|
|
3,132
|
| 28850 |
HSC (KSL)
|
|
interacts (colocalizes) with
|
SNO cell (N-cadherin+CD45-)
|
in c-Myc-deficient mice via N-cadherin-mediated homotypic interaction
|
in vivo
|
|
15545632
|
|
3,182
|
| 29211 |
HSC (CD150+CD48-Lin-)
|
|
interacts (colocalizes) with
|
MSC (Nes+)
|
|
in vivo
|
|
20703299
|
|
3,198
|
| 29375 |
HSC (CD150+CD48-CD41-Lin-)
|
|
interacts (colocalizes) with
|
sinusoidal endothelium (MECA-32+)
|
irrespective of the amount of osteoblasts in biglycan-deficient mice
|
in vivo
|
|
18371351
|
|
3,378
|
| 31432 |
HSC (CD150+CD48-CD41-Lin-)
|
|
interacts (colocalizes) with
|
endosteum (Annexin2+)
|
|
in vivo
|
|
21108988
|
|
3,403
|
| 31644 |
HSC (CD150+CD48-CD41-Lin-)
|
|
interacts (colocalizes) with
|
sinusoidal endothelium (MECA-32+)
|
|
in vivo
|
| 31646 |
HSC (CD150+CD48-CD41-Lin-)
|
|
interacts (colocalizes) with
|
BM cell (CD45-SSEA4+Angpt3+)
|
|
in vivo
|
|
20959605
|
|
3,524
|
| 32857 |
HSC (LRC, CD135-KSL)
|
|
interacts (colocalizes) with
|
trabecular bone
|
67 % of the quiescent HSCs are localized in the TBR and only 31% reside in CBR
|
in vivo
|
| 32859 |
osteoblast (N-cadherin+)
|
|
interacts (colocalizes) with
|
trabecular bone
|
|
in vivo
|
| 32860 |
HSC (LRC, CD135-KSL)
|
|
interacts (colocalizes) with
|
osteoblast (N-cadherin+)
|
|
in vivo
|
|
22817897
|
|
3,583
|
| 33556 |
HSC (CD150+CD48-Lin-)
|
|
interacts (colocalizes) with
|
sinusoidal endothelium
|
|
in vivo
|
| 33563 |
HSC (CD150+CD48-Lin-)
|
|
interacts (colocalizes) with
|
perivascular cells (SCF+)
|
|
in vivo
|
|
22281595
|
|
3,673
|
| 35200 |
HSC (TNR.GFP+KSL)
|
|
interacts (colocalizes) with
|
sinusoidal endothelium (VE-cadherin+)
|
|
in vivo
|
|
20207228
|
|
3,680
|
| 35297 |
non-myelinated Schwann cell (GFAP+)
|
|
interacts (colocalizes) with
|
HSC (CD150+CD48-CD41-Lin-)
|
about 23% of the HSCs were in contact with the Schwann cells
|
in vivo
|
| 35298 |
osteoblast (osteocalcin+)
|
|
interacts (colocalizes) with
|
HSC (CD150+CD48-CD41-Lin-)
|
about 13% of the HSCs were in contact with osteocalcin-expressing osteoblasts
|
in vivo
|
| 35299 |
sinusoidal endothelium (VE-cadherin+)
|
|
interacts (colocalizes) with
|
HSC (CD150+CD48-CD41-Lin-)
|
about 30% of the HSCs were in contact with VE-cadherin-expressing vascular cells
|
in vivo
|
|
22118468
|
|
3,687
|
| 35395 |
monocytes-macrophage (alpha-SMA+)
|
|
interacts (colocalizes) with
|
HSC (CD150+CD48-CD41-)
|
in bone marrow
|
in vivo
|
| 35491 |
monocytes-macrophage (alpha-SMA+)
|
|
interacts (colocalizes) with
|
MSC (Nes+)
|
|
in vivo
|
|
22983360
|
|
3,689
|
| 35517 |
macrophage (CD169+)
|
|
interacts (colocalizes) with
|
MSC (Nes+)
|
|
in vivo
|
| 35933 |
macrophage (CD169+)
|
|
interacts (colocalizes) with
|
MSC (Nes+)
|
|
in vivo
|
|
21282381
|
|
3,800
|
| 37764 |
HSC (N-cadherin+c-Kit)
|
|
interacts (colocalizes) with
|
endosteal cell (N-cadherin+)
|
|
in vivo
|
| 37769 |
HSC (N-cadherin+Tie2+)
|
|
interacts (colocalizes) with
|
endosteal cell (N-cadherin+)
|
|
in vivo
|
|
17897629
|
|
3,803
|
| 37806 |
HSC (CD150+CD48-CD41-Lin-)
|
|
interacts (colocalizes) with
|
stromal cell (JamB+)
|
in a JamC (Jam3)-dependent manner
|
in vivo
|
|
21868569
|
HSC